Healthcare & Life Sciences
Ocular Therapeutix
United Stateswww.ocutx.com
Ocular Therapeutix is a Healthcare & Life Sciences startup based in the United States, most recent round Series C+, 2 tracked investors.
Activeseries-c-plus
series-c-plus
Stage
2
Investors
About Ocular Therapeutix
Ocular Therapeutix is a startup based in the United States. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Ocular Therapeutix develops pharmaceutical therapies for retinal diseases, including an investigational axitinib hydrogel (AXPAXLI™) currently in Phase 3 clinical trials for wet age-related macular degeneration (AMD).
Explore Ocular Therapeutix's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.